After receiving his Doctor of Pharmacy, Ronan LE BOT started his career in the industry. A variety of professional experiences and more particularly with AVENTIS allowed him to gain a highly-specialized expertise in preclinical evaluation of drug candidates. In October 2005, Ronan LE BOT created Atlantic Bone Screen together with the scientific team members, and became CEO and main shareholder.